Panelist: Todd Callender Esq.. Director & General Counsel, Genesis Medical Technologies Industry
Expert: John Garrison, CEO, American Lung Association

    Governments around the world are beginning to recognize that preventive health care is more cost effective and less burdensome than the traditional focus on the treatment of disease. As a result, a shift is beginning in public healthcare, away from treatment to mass vaccination programs. However, this shift toward improving the healthcare industry via mass vaccination carries with it a few health risks of its own.

    According to reports from the World Health Organization, of the three billion injections given each year in mass vaccination programs, more than half of the injections are unsafe to either the healthcare workers or the patients. Among other sources of problematic injections, disposable conventional syringes use needles that pose needle stick health risk issues as well as unintended reuse. The dangers inherent in these problems could become catastrophic as we enter the 21st century.

    Considering the ever mounting risk of infectious diseases such as AIDS and Hepatitis, disposal of used needles is of great environmental concern. With more than 12 billion injections given (worldwide) each year, the magnitude of both the environmental threat and contamination costs requires an immediate response. The cost of proper disposal. as specified by the US Environmental Protection Agency alone, costs health care institutions millions of dollars every year in the US alone.

    Genesis Medical Technologies, Inc. has developed a medical solution that could virtually erase the dangers imposed by these mass injections. The company produces a needleless injector, which eliminates the 151K of accidental needle stick and the possibility of accidental reuse.

     Todd Callender, Esq.. general counsel and a director of Genesis Medical Technologies. Inc., appears as a guest on Wor/d Business Review to discuss how public healthcare programs worldwide can benefit financially and medically from the use of needleless injections. Callender specializes in international law and U.S. extraterritorial law, practicing in the Caribbean and Eastern Europe, including Cuba and Poland.

     The Genesis Medical Tech system of injection includes a spring loaded, self contained mechanically powered, fail safe operation. The injection is impact resistant, using a simple, sturdy construction with few moving parts that can provides hundred of injections per delivery device. The injection is contained in a plastic housing that makes the unit light, durable, portable and washable.

     Via this form of "jet injection", medication is delivered through a microscopic hole in the ampule, resulting in a pure, uncontaminated stream of medicine traveling through the patient's skin in less than half a second.

    Each needleless injector uses disposable plastic ampules to hold and deliver the medication. Individual ampules are designed for one time only use, making cross contamination or accidental contamination a risk of the past.

    The injectors are usable with or adaptable to a wide variety of pharmaceuticals requiring intramuscular or subcutaneous injection.

    Three items make up the Genesis Jet Injection system: the delivery device, the disposable medication ampule (sold either prefilled by a pharmaceutical manufacturer or empty for user filling) and a cocking device. As each delivery device is warranted for two hundred inoculations, ampules are to be sold in gross.

    The construction system of the Genesis device is the real key to its tremendous potential in the marketplace. Unlike any other product, all items comprising the Genesis jet injection system, including the delivery device are constructed mostly of high grade molded plastic with metal spring works and triggering mechanisms. The design is intensely simple with a minimum of moving parts.

    The simplicity of design, which allows for molded plastic construction, also allows for extremely low production costs, foolproof, ease of operation, and rugged reliability, even suited for field use under adverse conditions. It is critical to understand the quantum leap the Genesis device has taken over all other products. In fact, the Genesis device's only real competition is the hypodermic needle itself, not other jet injection systems in terms of cost, ease of use, portability, reliability, and efficacy.

    The Genesis delivery system, which will guarantee 200 applications, will wholesale at $30, with individual, sterilized, single dose ampule prices averaging $0.30 each. This pricing structure, simple design, rugged construction, and reliable performance seems to put the Genesis delivery system in a category by itself.

    Forward inquiries about Genesis Medical Technologies to Todd Callender at 242-362-2465 or by email: toddcallender@netscape.net . For more information about the company and its products visit its Web site at www.genmedtech.com or contact World Business Review at info@wbrtv.com.